News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canaan Partners Raises $600 Million Fund; $200 Million Will be Dedicated to the Life Sciences, Medical Device



1/10/2012 8:25:30 AM

Canaan Partners, a global venture fund with $3.5 billion under management, has raised $600 million to invest in technology and health-care companies. Canaan, based in Menlo Park, California, will spend two- thirds of the fund on digital media, Internet, mobile and other technology companies, and a third is designated for pharmaceutical, medical device and health-care investments, the company said today in a statement. This is Canaan’s ninth fund. Previous investments included Advanced BioHealing Inc., maker of Dermagraft, a bio-engineered skin substitute used to treat diabetic foot ulcers, which was acquired by Shire Plc in May for $750 million, and flash storage maker SandForce Inc., was acquired by LSI Corp. for $370M earlier this month.

Read at BusinessWeek
Read at Fortune
Read at News Release
Read at India Times


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES